Proceedings of the National Academy of Sciences · 2010 · 231 citations · 54 references
Life SciencesCell BiologyImmunologyCellular ImmunologyCytoskeletonMolecular VirologyActin PolymerizationAntiretroviral TherapyAntiviral ImmunityLymphocyte ActivationT Cell ActivationViral LatencyCell ActivationHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyHuman Immunodeficiency Virus LatencyHuman Immunodeficiency Virus PersistenceProtein DephosphorylationRecirculationT-cell Immune Responses
Eradication of HIV-1 with highly active antiretroviral therapy (HAART) is not possible due to the persistence of long-lived, latently infected resting memory CD4(+) T cells. We now show that HIV-1 latency can be established in resting CD4(+) T cells infected with HIV-1 after exposure to ligands for CCR7 (CCL19), CXCR3 (CXCL9 and CXCL10), and CCR6 (CCL20) but not in unactivated CD4(+) T cells. The mechanism did not involve cell activation or significant changes in gene expression, but was associated with rapid dephosphorylation of cofilin and changes in filamentous actin. Incubation with chemokine before infection led to efficient HIV-1 nuclear localization and integration and this was inhibited by the actin stabilizer jasplakinolide. We propose a unique pathway for establishment of latency by direct HIV-1 infection of resting CD4(+) T cells during normal chemokine-directed recirculation of CD4(+) T cells between blood and tissue.
54
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Tae‐Wook Chun, Lucy M. Carruth, Diana Finzi et al. · Nature · 1997 · 2.1K citations